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ABSTRACT
The preparation and high-throughput sequencing of
cDNA libraries from samples of small RNA is a pow-
erful tool to quantify known small RNAs (such as
microRNAs) and to discover novel RNA species. In-
terest in identifying the small RNA repertoire present
in tissues and in biofluids has grown substantially
with the findings that small RNAs can serve as in-
dicators of biological conditions and disease states.
Here we describe a novel and straightforward method
to clone cDNA libraries from small quantities of input
RNA. This method permits the generation of cDNA
libraries from sub-picogram quantities of RNA ro-
bustly, efficiently and reproducibly. We demonstrate
that the method provides a significant improvement
in sensitivity compared to previous cloning methods
while maintaining reproducible identification of di-
verse small RNA species. This method should have
widespread applications in a variety of contexts, in-
cluding biomarker discovery from scarce samples of
human tissue or body fluids.
INTRODUCTION
MicroRNAs (miRNAs) are small regulatoryRNAs, present
in all animal cells, that post-transcriptionally regulate
protein-coding messenger RNAs (mRNAs) (1). In addition
to being expressed inside cells, miRNAs can be detected
in stable complexes circulating in human body fluids (2–
5). Circulating miRNAs have since been identified in blood
serum/plasma, cerebrospinal fluid, saliva and urine (6), and
the profile of expressed miRNAs has been found to be al-
tered in disease states. As such, miRNAs offer the exciting
potential for use as non-invasive biomarkers for the diagno-
sis of disease and/or the monitoring of disease progression
and treatment (2–5).
Current methods for identification and quantification
of circulating miRNAs include microarray and quan-
titative real-time polymerase chain reaction (qRT-PCR)
hybridization-based techniques (7–9), as well as the iden-
tification and quantification of both known and novel
miRNAs through deep sequencing of small RNA-derived
cDNA libraries (10,11). Importantly, unlike hybridization-
based approaches, deep sequencing is not limited by assay
content and enables single-nucleotide resolution of RNA
species revealing the presence of unannotated miRNAs in-
cluding novel miRNAs and isoforms of known miRNAs
(isoMirs) (12).
Conventional approaches to preparing cDNA libraries
from small RNAs (sRNAs) rely on T4 RNA ligase-
dependent ligations of adapter oligonucleotides to the 3′
and 5′ termini of isolated RNAs. These ligation products
are reverse transcribed and PCR amplified to generate a
cDNA library suitable for high-throughput sequencing (for
examples see (10) and (13)). One limitation of existing ap-
proaches is the need to begin with input RNA quantities
in the hundreds of picogram (pg) to microgram (g) range
to allow for losses during the various enzymatic reactions
and at multiple gel purification steps (as many as four) prior
to PCR amplification (14). Recent innovations include em-
ploying a single RNA-adapter ligation followed by reverse
transcription (RT) and circularization of cDNA. However,
these approaches still require micrograms of starting mate-
rial (11,15). Commercially available cDNA library prepa-
ration kits are optimized for input RNA in the microgram
range, and moreover can become prohibitively expensive
for multiple sample applications, and offer little latitude for
customization.
Recent studies identifying small RNAs as biomarkers for
disease (reviewed in (16) and (17)) highlight the potential
of applying cDNA cloning and deep sequencing in clinical
settings. However, low quantities (LQ) of material found
in biofluids and other clinically relevant samples pose sig-
nificant challenges for cDNA library preparation. Recent
advances in LQ cDNA cloning include the preparation of
miRNA cDNA libraries from 5 ng of total RNA extracted
from human blood plasma (14). Single cell RNA-seq meth-
ods have been described for surveyingmessengerRNAs, but
not for small noncoding RNAs (18–22). Therefore, for such
applications where sequences are unknown, sample is scarce
and especially where quantities of inputRNAare in the sub-
ng and pg range, novel methods are required for the efficient
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cloning of cDNA libraries from miRNAs and other small
noncoding RNAs.
In this paper, we present the development of a highly sen-
sitive LQ cloning method for the generation of cDNA li-
braries from very small quantities of RNA (pg and sub-
pg range) isolated from clinical samples of human blood
plasma. The method incorporates several novel compo-
nents including (i) the reduction of gel purification steps,
(ii) seamless transition between ligation and RT using se-
quential reactions in a single tube and (iii) incorporation of
biotinylated nucleotides in the RT reaction to permit effi-
cient purification of cDNA prior to PCR.
MATERIALS AND METHODS
Blood draw and plasma isolation
3× 10ml blood was collected in ethylenediaminetetraacetic
acid (EDTA) blood collection tubes and spun at 1100 × g
for 20min at 4◦C. Plasma from all three tubes was combined
into one large cryovial, aliquoted into 1 ml cryovials, and
stored at −80◦C.
Nucleic acid manipulations
1.7 ml siliconized (low retention) microcentrifuge tubes
were used whenever possible to facilitate maximum recov-
ery of material. For all reactions done in a PCR machine,
either 0.2 ml strip tubes or 0.2 ml 96-well plates were used
depending on sample size and number.
Synthetic miRNA mixtures
Obtained from Life Technologies, referred to as ‘LT-
miRmix’ (personal communication and Supplementary Ta-
ble S2), and Rui Yi lab, referred to as ‘29-miRmix’ (Supple-
mentary Table S3) (23).
Total RNA isolation
For total RNA extraction from samples of human blood
plasma, 250 l plasma aliquots (stored at −80◦C) were
thawed on ice and cleared by centrifugation at 16,000 rpm
for 15 min at 4◦C. 200 l of the supernatant was removed
and total RNA was extracted using Trizol, followed by ex-
traction with phenol/chloroform, and ethanol precipita-
tion at −80◦C overnight using polyacryl carrier (Molecular
Research Center) and 3M KAc. Precipitate was recovered
by centrifugation, washed with 200 l 70% ethanol, resus-
pended in 10.0 l RNase free water and stored at −80◦C.
Determination of plasma equivalents
‘Plasma equivalents’ refer to the relative amount of plasma
used to generate cDNA libraries from RNA isolated from
human blood plasma. Using the protocol described above,
10 l of RNA corresponds to approximately 200 l of
plasma.
Quantification of miRNA in total RNA from human blood
plasma
Approximate quantity of miRNA in samples of total RNA
isolated from human blood plasma was determined using
miR TaqMan real-time qPCR assays (Life Technologies),
with reference to a standard curve generated using a known
quantity of LT-miRmix. RT was performed using the miR-
223 specific stem-loop primer (ID 002295) and the Mi-
croRNA RT Kit (both Life Technologies). Reaction con-
ditions followed manufacturer’s instructions: 16◦C 30 min,
42◦C 30 min, 85◦C 5min. One microliter of the RT reaction
was used as template in reactions containing 1× miRNA-
specific TaqMan primers/probes in combination with 1×
TaqMan GeneExpression Master Mix (Life Technologies)
according to the manufacturer’s instructions in a total re-
action volume of 10.0 l. Samples were split and run as 3
× 3.0 l reactions along with a no template sample as a
negative control. PCR reaction conditions followed manu-
facturer’s instructions: 50◦C 2min, 95◦C 10min, 40× (95◦C
15 s, 60◦C 1 min). Assays were run on a 7900HT Fast Real-
Time instrument (Life Technologies).
Oligonucleotide substrates, adapters and primers
3′ adapter, 5′ adapters, RT oligonucleotides and PCR
primers (Tables 1 and 2) were obtained from Integrated
DNATechnologies (IDT). RT oligonucleotides wereHPLC
or PAGE purified by IDT.
Pre-annealing of reverse transcription primer and 3′ linker
oligonucleotide
5.0 l of 20 M modban 3′ adapter (IDT miRNA cloning
linker 1) (1) and 5.0 l of 20 M RT oligonucleotide (Ta-
ble 1) were incubated in 20.0 l total volume with anneal-
ing buffer (10 mM Tris-HCl pH 7.5, 50 mMNaCl, 1.0 mM
EDTA). Annealing reactions were performed in a thermo-
cycler with a 105◦C heated lid as follows: 95◦C 1 min, cool
1◦C every minute for 85 min.
1.0 pmol of annealed product (3′ adapter::RT oligo)
was analyzed on an 8% non-denaturing polyacrylamide gel
(29:1) to confirm annealing.
3′ ligation reactions
5.0 pmol of annealed 3′ adapter::RT oligo product was incu-
bated with various quantities of either a synthetic miRNA
mixture or total RNA from human plasma (Table 3). 10.0
l reactions contained 50 mM Tris-HCl pH 7.5, 10 mM
MgCl2, 10 mM DTT, 0.1 g/l BSA, 15% DMSO and 1.0
l T4 Rnl2 truncated K227Q (24). The T4 Rnl2tr K227Q
was prepared using Addgene plasmid 14072 as described in
(25). Samples were incubated for 6 h at 30◦C in a PCR ma-
chine with a 105◦C heated lid.
First-strand cDNA synthesis
RT of ligation products was performed directly in the lig-
ation reaction mixture after completion of ligation by ad-
dition of the following: 5.0 l of 4× RT reaction buffer
(100 mM Tris-HCl pH 8.0, 300 mM KCl), 5.0 l of 4× RT
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Table 1. 3′ adapter and reverse transcription oligonucleotide sequences
name 5' mod oligo sequence 3' mod
3' adapter rApp CTGTAGGCACCATCAAT ddC
5' adapterA TCTACrArGrUrCrCrGrArCrGrArUrCrUrGrArC
5' adapterB TCTACrArGrUrCrCrGrArCrGrArUrCrCrArGrU
bar01 Phos GNN NNT GAG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar02 Phos GNN NNA ACG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar03 Phos GNN NNG GCG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar04 Phos GNN NNG ATG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar05 Phos GNN NNA GTG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar06 Phos GNN NNC CCG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar07 Phos GNN NNT TCG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar08 Phos GNN NNT CTG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar09 Phos GNN NNC TTG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar10 Phos GNN NNT AAG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar11 Phos GNN NNT CAG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar12 Phos GNN NNT GTG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar13 Phos GNN NNT TGG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar14 Phos GNN NNT ATG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar15 Phos GNN NNA CTG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar16 Phos GNN NNA CAG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar17 Phos GNN NNA AGG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar18 Phos GNN NNT GTG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar19 Phos GNN NNG TTG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar20 Phos GNN NNA TTG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar21 Phos GNN NNACATGTG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar22 Phos GNN NNACGATAG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar23 Phos GNN NNAGACTCG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar24 Phos GNN NNATCGCAG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar25 Phos GNN NNCAGAGTG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar26 Phos GNN NNCATCTCG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar27 Phos GNN NNGATACAG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar28 Phos GNN NNGTAGCTG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar29 Phos GNN NNTCTGCTG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar30 Phos GNN NNTGCTCAG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar31 Phos GNN NNATCTCGG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar32 Phos GNN NNGTCTATG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar33 Phos GNN NNTCAATCG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar34 Phos GNN NNCGAATGG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
bar35 Phos GNN NNNNAAGAACG ATC GTC GGA CTG TAG AAC G/ideoxyU//ideoxyU// ideoxyU/CC GAT TGA TGG TGC CTA CA 
3′ adapter and reverse transcription (RT) oligos used in ligation and RT reactions. 5′ and 3′ end modifications are as indicated. 5′ adapters contain RNA
nucleotides (r) and a 4 nucleotide (nt) barcode (blue). RT oligos contain a 4 or 6 (nt) randomer (NNNN or NNNNNN in red), a 3–6 nt barcode (blue)
and 3 internal deoxyUradine (ideoxyU).
Table 2. PCR oligonucleotide sequences
Name PCR round End Sequence End
Ion A short 1 5′ ATTGATGGTGCCTACAG 3′
Ion P1 short 1 5′ GATCTACAGTCCGACGATC 3′
Ion P1 long 2 5′ CCATCTCATCCCTGCGTGTCTCCGACTCAGATTGATGGTGCCTACAG 3′
Ion A long 2 5′ CCACTACGCCTCCGCTTTCCTCTCTATGGGCAGTCGGTGATCTACAGTCCGACGATC 3′
DP3 1 5′ ATTGATGGTGCCTACAG 3′
DP5 1 5′ GTTCTACAGTCCGACGATC 3′
Solexa 3 2 5′ ACAGCAGAAGACGGCATACGAATTGATGGTGCCTACAG 3′
Solexa 5 2 5′ AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGACGAT 3′
DNA oligonucleotides used in first (1) and second (2) rounds of PCR amplification for sequencing on the Ion Torrent (indicated by prefix ‘Ion’) or Illumina
(DP3, DP5, Solexa 3 and Solexa 5) platforms.
master mix (0.25 mM dGTP, 0.25 mM dTTP, 0.1625 mM
dCTP, 0.175 mM dATP, 0.0875 mM Biotin-dCTP (Trilink
Biotin-16-AA-2′dCTP), 0.075 mM Biotin-dATP (Metki-
nen Biotin-11-dATP), 20 units RNase inhibitor, 0.5 units
Invitrogen Superscript III Reverse Transcriptase, a ther-
mally stable RT enzyme, lacking terminal transferase activ-
ity (Life Technologies product literature). Samples were in-
cubated for 5 min at 45◦C followed by 5 min at 85◦C in a
thermocycler with a 105◦C heated lid.
For the LQ− biotin Library (10D), cDNAwas generated
as described above except with 10 mM dNTP containing
equal molar concentrations of dGTP, dTTP, dCTP, dATP,
and no biotinylated nucleotides.
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Removal of template RNAand ethanol precipitation of cDNA
reaction products
To hydrolyze RNA in the sample after RT, 1.8l 1MNaOH
was added to each RT reaction, samples were incubated for
20 min at 98◦C in a PCR machine with a 105◦C heated lid
and were neutralized by adding 1.8 l 1M HCl (26).
cDNAs were ethanol precipitated by bringing each re-
action up to 200 l with RNase free H2O, transferring
to a clean, 1.7 ml siliconized (low-retention) microcen-
trifuge tube, adding 2.0 l polyacryl carrier (Molecular
Research Center), 40.0 l 10M CH3COONH4, 3 volumes
100% ethanol, and incubating at room temperature for a
period of 1 h − overnight. Following room temperature
incubation, precipitate was recovered by centrifugation at
16,000 rpm for 30 min at room temperature in a microcen-
trifuge. The supernatant was removed and the pellet was
washed with 200 l 80% ethanol and spun for 15 min at
16,000 rpm at room temperature. The supernatant was re-
moved, the pellet was washed with 200 l 70% ethanol and
spun for 15 min at 16,000 rpm at room temperature. The
supernatant was removed and the pellet was resuspended in
10.0 l circular ligation reaction mix (see below).
Circular ligation reactions
Ethanol precipitated cDNA reaction product (see above)
was resuspended in 10.0 l circular ligation reaction mix
containing 1.0 l 10× reaction buffer (0.33M Tris-acetate
pH 7.8, 0.66M potassium acetate, 5 mM DTT), 2.5 mM
MnCl2, 1M betaine and 1.25 units CircLigase II ssDNA
Ligase (Epicentre). Reactions were incubated at 60◦C for
2 h.
Gel fractionation, elution and isolation of biotinylated cDNA
Circularized cDNAs and circular single-stranded DNA
molecular weight markers were fractionated on separate
lanes of a 10% polyacrylamide/7M urea gel. The gel was
stained with SYBR Gold (Life Technologies) according to
manufacturer’s instructions, visualized on a blue light tran-
silluminator and circularized cDNAsmigrating in the range
of 80 –100 nt were excised. Each gel slice was added to
a 1.7 ml siliconized (low-retention) microcentrifuge tube
containing 400 l TE + 0.3M NaCl. 5.0 l magnetic hy-
drophilic streptavidin beads (New England Biolabs) were
washed three times with 50 l buffer WB (0.5M NaCl, 20
mM Tris-HCl pH 7.5, 1.0 mM EDTA), resuspended in 5.0
l TE + 0.3M NaCl and added to each sample. Tubes were
shaken overnight at 1,100 rpm at room temperature. Af-
ter overnight elution, the bead-containing supernatant was
transferred to a clean, low-retention 1.7 ml eppendorf tube,
tubes were magnetized on a magnetic rack (Life Technolo-
gies), supernatants carefully removed, beads washed three
times with 1.0 ml buffer WB (magnetizing and carefully
removing supernatant between each wash step) and resus-
pended in 10.0 l RNase free H2O.
For the LQ − biotin library (10D), gel fractionation and
elution was done as above except magnetic streptavidin
beads were excluded. After overnight shaking, buffer con-
taining eluted material was removed, added to a 0.45 m
spin column and spun 3 min at 3,000 rpm at room tem-
perature into a clean, 1.7 ml siliconized (low-retention) mi-
crocentrifuge tube. Circularized cDNAs were ethanol pre-
cipitated by adding 2.0 l polyacryl carrier (Molecular Re-
search Center), 1/10 volume 3M KAc pH 5.0, 3 volumes
100% ethanol, and incubating at -80◦C for 1 h. Following
-80◦C incubation, precipitate was recovered by centrifuga-
tion at 16,000 rpm for 20 min at 4◦C in a microcentrifuge.
The supernatant was removed, the pellet was washed with
200 l 80% ethanol and spun for 15 min at 16,000 rpm at
4◦C. The supernatant was removed, the pellet was washed
with 200 l 70% ethanol and spun for 15 min at 16,000 rpm
at 4◦C. The supernatant was removed and the pellet was re-
suspended in 10.0 l RNase free H2O.
First round PCR library amplification of cDNA library
PCR amplification was performed using 2× TaqMan Gene
Expression Master Mix (Life Technologies) using 50% of
the bead suspension from above in a 50.0 l reaction with
a final concentration of 0.1 M forward and 0.1 M re-
verse Round 1 PCR primers (Table 2) for up to 25 cycles
removing 10.0 l every 2 cycles starting at 12 cycles. PCR
reactions conditions were: 55◦C 2 min, 95◦C 10 min, 12–
25× (95◦C s, 55◦C 1 min), 10◦C hold. Samples were run on
an 8% non-denaturing polyacrylamide gel (29:1). The gel
was stained with SYBR Gold (Life Technologies) per man-
ufacturer’s instructions and visualized on a blue light tran-
silluminator. Appropriate 65 –70 nucleotide PCR products
(Supplemental Table S1) were excised at the cycle number
when first visible, gel slices cut in half vertically, and stored
at -20◦C.
Second round PCR amplification of cDNA library
PCR amplification was performed using 2× AmpliTaq
Gold Fast PCR master mix (Life Technologies) using one-
half of the first round PCR product gel slice as template in a
100 l reaction with a final concentration of 0.125 M for-
ward and 0.125 Mreverse Round 2 PCR primers (Table 2)
and 8 –12 cycles. Care should be taken to isolate PCR prod-
ucts at low cycle number, before primers are depleted and
bulged PCR products appear. (Such bulged products result
fromdenatured products that anneal at the adaptors but not
at the center, and appear as a smear migrating slower than
the desired PCR product.) An initial 20–30 l PCR reac-
tion, removing samples at 8, 10 and 12 cycles and resolving
on an 8% non-denaturing polyacrylamide gel (29:1), can be
performed to determine optimal cycle number. PCR reac-
tions conditions were: 95◦C 10min, 8 –12× (95◦C 15 s, 60◦C
1 min), 10◦C hold.
Purification and quantification of second round PCR product
Appropriate 116–138 nucleotide second round PCR prod-
ucts (Supplementary Table S1) were purified using BioBa-
sic Inc. EZ-10 Spin Column PCR Purification Kit follow-
ing manufacturer’s recommendations. Samples were eluted
in 30 l kit-provided elution buffer and quantified using an
8% non-denaturing polyacrylamide gel (29:1) and a known
DNA standard (i.e. New England Biolabs Low Molecular
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Weight DNA ladder) as well as on a high-sensitivity DNA
BioAnalyzer chip (Agilent Technologies).
2-Linker cDNA library preparation
Libraries were generated as described in Gu et al. (13) with
minor modifications. The 3′ ligation was done as described
above and 5′ adapters contained the 3′ barcode as described
in Table 1.
Sample preparation and high-throughput sequencing
PCR products were sequenced on the Ion Torrent PGM,
Ion Torrent Proton or Illumina HiSeq2000 instrument ac-
cording to manufacturer’s protocols.
Computational pipeline
FastQ file formats contain the following data formats:
Ion Torrent sequences: (3′) adapter – sequence read –
GNX – barcode – adapter (5′)
Illumina sequences: (5′) barcode – NXC – sequence read
– adapter (3′)
For each library the following steps were applied:
1. Adapters were removed using theCutadaptmethod (ver-
sion 1.2.1) (27): using the -e 0.25 option and the follow-
ing adapter sequences:
For Ion Torrent sequences: -g ATTGATGGTGCC-
TACAG and -a GATCGTTCGGACTGTAGATC
For or Illumina sequences: -a CTGTAGGCACCAT-
CAAT
2. Sequences were split into libraries according to barcode.
3. Randomer sequences (NX) were removed and saved in
the header line of the fasta file for later PCR hotspot
analysis.
4. Reads <17 nt were filtered and removed.
5. For Ion Torrent sequences, reads were reverse comple-
mented.
6. Reads with identical sequences were combined and the
combined count was saved.
7. The count of each read was corrected by the ‘PCR
hotspot’ correction procedure described below.
8. Plasma and mixture libraries were further processed as
follows:
(A) For plasma libraries:
Reads were aligned to a reference sequence (see be-
low) using bowtie (28)
-v 3 -f -B 1 -a –best –strata
Alignments were then filtered based on the length of
the read and the number of mismatches as follows:
for sequence lengths 17, 18–19, 20–24 or>24: 0, 1,
2 or 3 mismatches were allowed, respectively.
(B) For miRNA mixture libraries:
(1) Reads were aligned to reference sequences (see
below) and (2) the reference sequences were
aligned to the reads using bowtie (28) -v 3 -f -
B 1 -a –best –strata
A reference set for the Life Technologies synthetic mix-
ture (LT-miRmix) libraries was constructed as follows:
1. All sequences that were present in mixture libraries 1-5B
(Table 3) were enumerated.
2. All sequences with more than 10 reads in ≥7 libraries
were identified. In addition, sequences with more than
50 reads in ≥1 library that were also annotated in the
miRNA mixture (Life Technologies, personal commu-
nication) were collected. Sequences were combined, re-
sulting in a total of 2,299 sequences.
3. Highly overlapping sequences with some 5′ and 3′ over-
hangs were clustered based on a 17 nt seed sequence, al-
lowing up to two mismatches.
4. Each cluster was represented by a sequence spanning
all sequences within the cluster, resulting in 1,047 se-
quences.
5. These final 1,047 sequences served as the miRNA mix-
ture reference set (Supplementary Table S2).
Defining a sub-reference set of the Life Technologies syn-
thetic mixture (denoted as LT-miRmix subset):
To perform an unbiased analysis of 5′ terminal additions
in the LQ method, which could be affected by the natural
heterogeneity present in the synthetic miRNA mixture, we
identified a set of 154 sequences with a fixed starting point
(exhibiting no heterogeneity in the 5′ end) for all the reads.
These sequences served as the reference set for analysis of 5′
nt additions, 3′ end variability and biotin-introduced mis-
match rate.
The reference set for the equimolar 29-miRNA synthetic
mixture was as described in Zhang et al. (23) and listed in
Supplementary Table S3.
Reference sets for the human blood plasma libraries
were:
1. The human genome sequence, hg19 downloaded from
UCSC (29).
2. A list of annotated sequences from the following re-
sources:
UCSC browser for rRNA, tRNA, snRNA and scRNA
sequences (29).
piRNA bank (30) for piRNA sequences.
fRNAdb (31) for yRNA and snoRNA sequences.
miRBase (32) (Release 20) for pre-miRNA and miRNA
mature sequences.
Analysis of mapping results
An in-house developed code was used to analyze the results
as follows:
1. For the synthetic miRNAmixture libraries the mapping
results of (i) reads to reference sequences and (ii) refer-
ence sequences to the reads were combined. (The latter
is needed in order to take into account potential 5′ or
3′ terminal additions.) A read count for each reference
sequence was assigned by taking into account all reads
associated with it and keeping track of the relative map-
ping alignment of each read for further analysis.
2. For plasma libraries the results of (i) mapping to the hu-
man genome sequence and (ii) mapping to small RNA
sequences were combined. Reads that mapped to the
genome with less mismatches than to a small RNA were
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Figure 1. Overview of 3-day generation of cDNA libraries. (A) On the first
day, total RNA is ligated to a 3′ adapter and cDNA is generated by reverse
transcription by tandem reactions in a single tube, RNA is degraded and
cDNAs are isolated by ethanol precipitation. (B) On the second day, cD-
NAs are circularized, size selected by gel fractionation and eluted overnight
in the presence of streptavidin beads. (C) PCR is done on bead-bound pu-
rified cDNAs to generate templates ready for high-throughput sequencing.
assigned as non-small RNA human genomematches. To
assign read counts to the miRNA sequences we consid-
ered all reads that mapped to a pre-miRNA sequence
within -5 to +5 nucleotides of the annotated mature
miRNA start according to miRBase. For all the other
small RNA species, we included all reads that map to
a small RNA reference sequence regardless of the map-
ping position.
For all comparisons done between libraries, a normalized
read count (i.e. reads per million of aligned reads) was used.
Analyzing miRmix subset sequences
To generate the averages presented in the G/U mutation
profile (Figure 5D), 5′ terminal additions profile (Figure
6A) and read length profile (Figure 6B), the synthetic
miRNA sequence reference sets were used as follows:
For each sequence the following were calculated:
1. The percent ofmismatches among themapped reads (for
G or U nucleotides separately).
2. The percent of mapped reads that had a 5′ overhang (of
up to 5 nucleotides) beyond the fixed starting point of
the sequence.
3. The distribution of read length among themapped reads.
The averages across all the sequences for each of the mea-
sures in points 1–3 are displayed in the figures mentioned
above.
PCR hotspot correction
For each sequence in a given library, we stored the randomer
sequence (NX) associated with it (Step 3 of the computa-
tional pipeline). These randomers were used for:
(A) Assessing the distribution of randomers from the se-
quencing data by:
BARNXGdU/dU/dU
+
ddC - 3’5’ - rApp
5’ - -OH - 3’
- 5’3’ -
RNA
3’ adapter
RT oligo
A
5’ - ddC - 3’
free adapter::primer
RNA-ligated adapter::primer
BARNXGdU/dU/dU - 5’3’ -
BARNXGdU/dU/dU
ddC - 3’5’ - rApp
- 5’3’ -
ddC - 3’5’ -
B   B       B         B
“no insert” cDNA
“+ insert” cDNA
BARNXGdU/dU/dU - 5’
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G  
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“no-insert” 
circularized cDNA
 B
AR
N XG
dU/dU/dU
“+ insert” 
circularized cDNA BA
RN
X
G
dU/dU/dU
B
B
B B
Figure 2. Detailed LQ cloning method. (A) A pre-adenylated (rApp) 3′-
terminal dideoxy-C (ddC) blocked adapter (gray) is annealed to a ssDNA
reverse transcription (RT) oligo (black) in a 1:1 molar ratio. The annealed
adapter is ligated to 3′-hydroxyl-containing RNA (orange) using T4 RNA
Ligase 2 (truncated K227Q) without ATP. Each RT oligo contains a 5′
Guanine (G) followed by a 4 or 6 nucleotide randomer (NX), a 3–6 nu-
cleotide barcode (BAR) and 3 internal deoxyUridine (dU) nucleotides.
The adapter::RT oligo hybrid is in excess over RNA, resulting in free
adapter::primer material present in the completed reaction. (B) Reverse
transcription of ligated RNA is carried out in the same tube as the liga-
tion reaction generating ‘+ insert’ and ‘no insert’ cDNA products (red and
black line) using dGTP, dTTP, dATP, dCTP as well as biotinylated dATP
and dCTP (yellow ‘B’-containing circles). The RNA template is degraded
(dashed orange line) by base hydrolysis and cDNA is ethanol precipitated
with ammonium acetate to facilitatemaximum removal of free adapter and
unincorporated nucleotides (C). Ethanol precipitated cDNAs are circular-
ized (D) and resolved on a 10% denaturing polyacrylamide gel. ‘+ insert’
circularized cDNAs are isolated by excising and eluting them from the gel
overnight in the presence of magnetic streptavidin beads (E). Bead-bound
‘+ insert’ cDNAs serve as templates in the first round of PCR. Amplifica-
tion is done using a mix containing uracil-N-deglycosylase (UNG) to re-
move dU nucleotides, thereby generating a linear template through strand
scission, and with primers complimentary to the 3′ adapter (blue) and 5′
end of the RT oligo (tan) (F). First round PCR products are resolved on
an 8% native polyacrylamide gel, the 60–70 nucleotide products are ex-
cised and a portion is used as the template for second round PCR. Second
round PCR products are generated using primers complimentary to the 3′
adapter (dark blue) and 5′ end of the RT oligo (brown) that contain the
full Illumina or Ion Torrent adapter sequences (dark blue and brown) (G).
1. Calculating the distribution of randomers associ-
ated with each sequence.
2. Identifying a set of sequences with random distribu-
tion of randomer sequences by:
(a) choosing a set of sequences that has more than
4X reads and
(b) identifying sequences within (a) where no ran-
domer is represented by >5% of the reads.
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FASTQ file
Trim 5’ and/or 3’
adapter
combine identical
sequence reads
remove
randomer
split sequences
by barcode
reads < 17nt
reads ≥ 17nt
randomer
sequence
filter PCR
“hot spots”
align combined
reads to reference
filter based on
mismatches/length
align combined
reads to reference
Plasma
Libraries
miRNA mixture
Libraries
align reference to
combined reads
retrieve counts
and alignments
Figure 3. Computational pipeline for analysis of deep sequencing libraries.
See Materials and Methods section for detailed explanation.
3. Determining the expected distribution of ran-
domers by calculating the average percentage
and the standard deviation for each randomer,
based on the sequences found in A2. We denote
the expected percentage for a randomer i as pi(
i ∈ {1..4x},∑4xi=1 pi = 100
)
.
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Figure 4. LQand 2-linker cloningmethods isolate small RNAs from a syn-
thetic miRNAmixture and total RNA from human blood plasma. (A) The
frequency of small RNA read lengths obtained from libraries generated
with decreasing amounts of the synthetic miRNA mixture using the LQ
method (black text) and the 2-linker method (gray line, red text). Library
designation indicated in (). Where multiple libraries are indicated, the dis-
tribution is shown as the average of these libraries. (B) The frequency of
small RNA read lengths in libraries generated using total RNA isolated
from human blood plasma is represented as the average across all plasma
libraries with error bars indicating the standard deviation.
(B) Identification of PCR hotspots for each combined
identical sequence in the library was done by:
1. Identifying randomers with an observed percentage
higher than the expected average plus three standard
deviations.
2. Let i be the randomer identified in B1, with an ex-
pected percentage pi (calculated in A3) and an ob-
served count ci. Let n be the total read count ob-
served for the current sequence. The new total count
n′ can be corrected to n′ = (n−ci )∗100(100−pi ) . The observed
count for randomer i is corrected to pi ∗ n′.
3. Correcting the observed distribution of randomers
for all the other randomers based on their ci and n′.
4. Repeating steps B2 and B3 until no corrections are
needed or until the total sequence count equals the
number of randomers identified for that sequence.
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Figure 5. Evaluation of LQ cloning method accuracy. Histograms repre-
senting the profile of the nucleotide at the 5′ end (A) and 3′ end (B) of reads
mapped to the LT-miRmix in each library using the LQ method (black
text) and 2-linkermethod (red text). LQ librarymade with heat prior to the
RT is shown in brown text and LQ library made without biotin is shown
in purple text. (C) The frequency of reads cloned versus combined total
G/U content of reads using the LQ method (black text) and the 2-linker
method (red text, gray line). Library designation indicated in (). Where
multiple libraries are indicated, the distribution is shown as the average
of these libraries. (D) Histogram representing the percentage of Guanine
(G) and Uracil (U) mutated in reads mapped to the LT-miRmix subset
reference in libraries generated using either the LQ method (black text) or
2-linker method (red text).
Note: If, for a given sequence, only a subset of randomers
is observed, then the expected distribution of these ran-
domers is scaled so that their total summation will be 100,
and 0 is assigned in the pi of the other randomers. This step
is needed in order to avoid collapsing of reads with under-
representation of randomers (due to initial low abundance
of the read(s)).
RESULTS
Key features of the method
Overview. Our aim was to establish a method for prepar-
ing cDNA libraries for high-throughput sequencing from
a very low quantity (LQ) of input RNA. Accordingly,
we developed a relatively straightforward and streamlined
cloning protocol that minimizes sample loss by reducing
the number of sample extraction and gel purification steps
compared to conventional cloning protocols while enabling
cloning from significantly less material compared to com-
mercially available streamlined methods. We also incorpo-
rated provisions for sample multiplexing and future devel-
opment of high-throughput applications. Our protocol in-
volves sequential linker ligation and RT reactions in a sin-
gle tube (Figure 1A), where a single adapter is ligated to
the 3′ end of the RNA, followed by generation of biotin-
containing reverse transcribed cDNAs. cDNAs are then cir-
cularized, the biotin-containing cDNAs are isolated (Fig-
A
B
Enzyme Reaction Average terminal
Library (U) time (min) addition (%)
D1 100 90 22.33
D2 100 5 12.53
1 0.5 5 1.33
2A 0.5 5 1.95
2B 0.5 5 2.08
2C 0.5 5 2.27
2D 0.5 5 2.48
3 0.5 5 0.34
4A 0.5 5 0.90
4B 0.5 5 0.91
4C 0.5 5 0.99
4D 0.5 5 1.32
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Figure 6. Examination of 5′ and 3′ end variation inmiRNAmixture cloned
sequences from the LT-miRmix. (A) Table demonstrating reverse tran-
scription reaction conditions and corresponding average percentage of 5′
terminal additions computed on LT-miRmix subset reference (see Materi-
als andMethods section). LibrariesD1 andD2 (Development 1 andDevel-
opment 2, respectively) represent libraries examined early in method devel-
opment with variedRT reaction conditions as indicated. (B) The frequency
of small RNA read length for those miRNAs with a fixed 5′ end indicating
3′ end variation across examined libraries. Library designation indicated
in (). Where multiple libraries are indicated, the distribution is shown as
the average of these libraries.
ure 1B) and libraries are amplified by PCR (Figure 1C).
This streamlined method allows for preparation of libraries
ready for quantification and sequencing in 2–3 days (Figure
1). The steps of the protocol are diagrammed in Figure 2
and described in detail in the Materials and Methods sec-
tion. Specific features of the protocol that contribute to its
enhanced sensitivity and simplicity are presented below.
Single-tube, sequential ligation and reverse transcription re-
actions. Ligation reactions are performed with truncated
and mutated T4 RNA Ligase 2 (T4Rnl2tr K227Q) at 30◦C
for 6 h. T4Rnl2tr K227Q carries out a more specific and ef-
ficient ligation between RNA and 3′ adapter compared to
wild-type T4Rnl2 and the 30◦C ligation reaction temper-
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Figure 7. Analysis of synthetic miRNAs captured by the LQ cloning method. Deep sequencing data of an equimolar mixture of 29 synthetic miRNAs (29-
miRmix) (23) before (gray bars) and after (blue bars) removal of sequences generated by PCR hotspots. The proportion of total reads (Y axis) for each
miRNA (X axis) is plotted. The amount of input RNA (2.5 pmol–500 amol) and 3′ adapter (10 pmol or 1 pmol) are indicated. All 3′ adapters were
pre-annealed to an equal concentration of RT oligo (see Materials and Methods section) and all RT oligos have a 4 nt randomer sequence. Dashed line
represents the expected result for equimolar sequence representation and miRNAs with ≥50% G/C content are indicated with red text.
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Library 1 2A 2B 2C 2D 3 4A 4B 4C 4D 5A 5B 10A 10B 10C 10D Library
1 0.93 0.86 0.90 0.79 0.64 0.92 0.85 0.90 0.79 0.36 0.50 0.75 0.73 0.79 0.77 1
2A 0.94 0.95 0.83 0.77 0.99 0.93 0.94 0.83 0.41 0.50 0.82 0.80 0.87 0.81 2A
2B 0.89 0.90 0.78 0.93 0.99 0.89 0.91 0.43 0.51 0.90 0.87 0.91 0.80 2B
2C 0.85 0.70 0.94 0.87 0.99 0.84 0.37 0.46 0.78 0.75 0.81 0.77 2C
 2D 0.73 0.83 0.89 0.84 0.99 0.36 0.43 0.82 0.83 0.82 0.71 2D
3 0.77 0.78 0.72 0.73 0.36 0.38 0.81 0.77 0.86 0.79 3
4A 0.94 0.95 0.84 0.40 0.50 0.82 0.80 0.87 0.81 4A
4B 0.89 0.91 0.41 0.49 0.90 0.87 0.91 0.80 4B
4C 0.85 0.36 0.46 0.78 0.76 0.81 0.77 4C
4D 0.36 0.44 0.83 0.84 0.83 0.72 4D
5A 0.62 0.45 0.40 0.43 0.41 5A
5B 0.48 0.45 0.45 0.49 5B
10A 0.95 0.95 0.85 10A
10B 0.92 0.81 10B
10C 0.90 10C
10D 10D
Figure 8. Comparison between cDNA libraries generated from the syn-
thetic miRNA mixture. Correlation coefficients (R) were computed using
read counts associated with each sequence in the LT-miRmix reference set.
Libraries were sequenced on the Ion Torrent (yellow) or Illumina (orange)
platform. Dark blue boxes highlight correlations between libraries gener-
ated fromdecreasing amount ofRNAand sequenced on either the IonTor-
rent or Illumina platform. Light blue boxes highlight correlations between
libraries made from identical input material and sequenced on both the
Ion Torrent and Illumina sequencing platforms. Brown box highlights cor-
relations between libraries made from identical input material with (10A)
or without heat (10B) prior to the RT. Purple box highlights correlations
between libraries made from identical input material with (10C) or with-
out (10D) Biotin incorporation. Correlations between libraries made with
9.1 or 0.9 pmol of input using the 2-linker cloning method (red text) are
highlighted in the red box.
ature reduces sequence biases that may be introduced by
RNA secondary structure such as stem-loops (33,34).
To promote efficient first-strand cDNA synthesis, the RT
primer oligonucleotide is pre-annealed to the 3′ adapter
(adapter::RT oligo; Figure 2A) prior to the ligation reac-
tion. This provides for maintaining equimolar stoichiom-
etry of the adapter and RT oligo throughout the ligation
and, importantly, pairs ligated RNA with a barcoded RT
oligo. Moreover, since no extraction or precipitation steps
occur after ligation, the pre-annealed RT primer serves as
a substrate for RT of ligated RNA in sequential single-tube
ligation andRT reactions. Accordingly, immediately follow-
ing ligation, the thermostable reverse transcriptase Super-
Script III (Invitrogen), RT buffer and reaction components
are added directly to the ligation mixture. This direct transi-
tion from the ligation to the RT reaction avoids a gel purifi-
cation step necessary in some other methods and hence re-
duces sample losses. Finally, by generating cDNAs at 45◦C,
efficient extension is achieved while maintaining annealing
of the 3′ adapter::RT oligo hybrid. Importantly, removal of
a denaturing step prior to the RT reaction did not inhibit
our ability to isolate sequences with high GC content (Sup-
plementary Figure S1) and libraries generated with (10B)
or without (10A) a 65◦C heat step for 5 min prior to the RT
correlated very well (Figure 8).
Novel features introduced into cDNAs. Notable features of
the RT oligo include a 5′ terminal Guanine (G) to mini-
mize nucleotide bias inherent to the circular ligase, a bar-
code to enable sample multiplexing, a randomer to identify
PCRhotspots (seeMaterials andMethods) and internal de-
oxyuracil (dUTP) nucleotides to enable linearization of cir-
cular cDNAs by Uracil-D-glycosylase (UDG, aka Uracil-
N glycosylase, UNG) in the first round of PCR (Table 1
and Figure 2). Finally, to promote efficient recovery of pu-
rified cDNA (Figure 2A), biotinylated dCTP and biotiny-
lated dATP are included in the cDNA reaction (Figure 2B
and Materials and Methods section). Importantly, biotiny-
lated nucleotides are required for recovery of cDNAs result-
ing from successful ligation reactions. In the absence of bi-
otin, only cDNAs reflective ofRToligos are recovered as ev-
idenced by short (44–49 nt) first round PCR products (Sup-
plementary Figure S2).
Circularization and isolation of biotinylated cDNA. Fol-
lowing first-strand cDNA synthesis, RNA is removed by
base hydrolysis and cDNAs are ethanol precipitated with
10M ammonium acetate at room temperature, facilitating
removal of free 3′ adapter and unincorporated nucleotides
(35,36) (Figure 2C). All recovered material is circularized
using CircLigase II (Epicenter) (Figure 2D) and fraction-
ated on a 10% denaturing gel to obtain circular single-
stranded DNA of the desired length: 69–74 nucleotides for
cloned small RNAs (Supplementary Table S1). This is the
only gel purification step in the protocol prior to sample
amplification, hence this step allows for size selection of cir-
cularized ‘+ insert’ products and also serves as a first step
in separation of ‘+ insert’ material away from ‘no insert’
material. Excised ‘+ insert’ cDNAs are eluted from the gel
overnight in the presence of streptavidin beads, allowing for
selective binding and hence a full isolation of biotin contain-
ing ‘+ insert’ cDNAs away from remaining ‘no insert’ (non-
biotinylated) material. Beads are washed and the strepta-
vidin bead-bound ‘+ insert’ cDNAs are amplified directly
from the beads in the first round PCR.
Utilization of deoxyuracil in PCR amplification of libraries.
In the first round of PCR, primers complementary to
sequences flanking the cloned sequence (Table 2, Figure
2E and F) and Taqman Gene Expression Master Mix
(Life Technologies) are added directly to streptavidin bead-
bound ‘+ insert’ material. UNG in the master mix en-
ables excision of dUTP from template molecules, promot-
ing strand scission and generation of a linear PCR template.
The master mix also contains a blend of dTTP/dUTP nu-
cleotides: incorporation of dUTP into new amplicons serves
to minimize carry-over PCR contamination between first
round products. First round PCR products are resolved on
an 8% non-denaturing polyacrylamide gel and appropriate
65–70 nt products are excised. Primers complementary to
the 5′ and 3′ sequences of first round PCR products that
include adapters specific for sequencing on either the Ion
Torrent or Illumina platform (Figure 2G and Table 2) are
then used in the second round of PCR for final library am-
plification prior to sequencing.
Computational analysis of cDNA libraries. In order to
identify cloned sequences, we use an in-house computa-
tional pipeline (Figure 3 and Materials and Methods sec-
tion). In this pipeline, first, 5′ and 3′ adapter sequences
(Ion Torrent-derived libraries) or 3′ adapter sequences
(Illumina-derived libraries) are removed. Second, by using
the unique 3–6 nucleotide (nt) barcode sequence incorpo-
rated into each library, multiplexed samples are split by
barcode. Next, the randomer sequences are removed and
saved for later PCR hotspot analysis. Reads are then fil-
tered for length. All sequences shorter than 17 nt are dis-
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carded, as this limited read length cannot be mapped with
high confidence. All remaining≥17 nt reads having an iden-
tical sequence are combined and counted. Identical reads
are checked for PCR hotspots by comparing the distribu-
tion of the randomers associated with each sequence to the
expected distribution of randomers (determined from the
sequencing data; see Materials and Methods section) and
filtered accordingly. Remaining reads are aligned to the ref-
erence sequences using the Bowtie alignment tool (28) fol-
lowed by a final filtering of reads based on length and mis-
match cut-offs as described in Materials and Methods sec-
tion.
Method evaluation and application
An ideal method for generating cDNA libraries from small
RNAs should be sensitive, reproducible over awide range of
input RNAquantity and should accurately represent the se-
quence profile of the input RNA. Therefore, we performed
rigorous assessments of these criteria by first creating li-
braries from the Life Technologies synthetic miRNA mix-
ture (LT-miRmix) using both our LQmethod and the estab-
lished 2-linker cloning method (13). While the LT-miRmix
is complex and better represents sequences that may be en-
countered in biological samples, limited sequence annota-
tion and unknown molarity for the contents of the LT-
miRmix led us to further examine the LQ method using
a well-characterized miRNA mixture (29-miRmix) com-
prised of 29 synthetic miRNAs with known stoichiometry
and sequence context (23). We also assessed the potential
applicability of our method in a clinical setting by cloning
cDNA libraries from small quantities of total RNA isolated
from human blood plasma.
Libraries generated using the synthetic miRNAmixtures
were used to assess the accuracy of the method in recov-
ering sequences in a standardized set of RNA. Sequences
obtained from cDNA libraries generated from the mixtures
were mapped to the LT-miRNAmixture reference set of se-
quences (Materials and Methods section and Supplemen-
tary Table S2) or the set of 29-miRNAs (Supplementary Ta-
ble S3). The accuracy of our method was then assessed in
terms of read length distribution, 5′ end identity and het-
erogeneity (particularly from potential terminal transferase
activity of the RT enzyme), 3′ end identity and heterogene-
ity, and potential sequence bias or mutagenesis introduced
through the use of biotinylated nucleotides. Central to this
assessment was a comparison of libraries generated using
the LQ method with and without biotin as well as to those
made with the biotin-free 2-linker approach.
cDNA library sequence overview. We generated libraries
from two synthetic miRNA mixtures, one containing ap-
proximately 1,000 miRNA sequences provided by Life
Technologies (personal communication and Supplemen-
tary Table S2) and a second containing 29 miRNAs (Sup-
plementary Table S3) (23), as well as total RNA isolated
from normal human blood plasma. The average number of
reads obtained from libraries sequenced on the Ion Torrent
and Illumina platforms ranged from 190,000 to>1,000,000
depending on the number of samples multiplexed and the
platform used (Table 3).
As expected, we found that as RNA input quantity de-
creased, the number of PCR cycles required to yield de-
tectable PCR product increased (Table 3). In general, in-
creasing the number of PCR cycles affected the percentage
of hotspots detected in our libraries, as evidenced by clus-
ters of identical reads containing an identical randomer se-
quence. We found that our libraries that required relatively
more PCR amplification steps could contain up to 14% of
total reads associated with hotspot amplification (Table 3).
These results emphasize the importance of including ran-
domer sequence tags in the cloning oligo backbone for the
identification and compression of hotspot reads.We also ex-
amined the impact of using a 6 versus a 4 nt randomer. In-
terestingly, we did not see any particular advantage to using
a longer randomer (Supplementary Figure S3).
After compression of hotspot sequence reads, remain-
ing reads were mapped to the reference sequence set cor-
responding to the source RNA: the synthetic mixture ref-
erence set for LT-miRNAmix libraries, the 29 miRNA se-
quences for 29-miRmix libraries, or the small RNA refer-
ence and the human genome for plasma-derived libraries
(Materials and Methods section). We observed the per-
centage of sequences that mapped to the respective ref-
erence sequences varied from 51% to 96%, somewhat de-
pendent upon the quantity of input RNA. For example,
in libraries generated from the synthetic miRNA mixtures,
greater quantities of input RNA tended to result in libraries
with higher percent mapping to the reference. However, for
libraries generated from lower amounts of input RNA, the
reference sequence coverage was still substantial (at least
93%) (Table 3).
For libraries generated from human blood plasma RNA,
we identified sequences corresponding to a broad reper-
toire of small RNAs matching the human genome. The
majority of sequences mapped to human miRNAs, while
the remainder mapped to ribosomal RNA (rRNA), trans-
fer RNA (tRNA) fragments, other circulating RNAs such
as Y RNA (37), and also sequences annotated as Piwi-
interacting RNAs (piRNAs) (38,39). Future study is re-
quired to assess the potential biological relevance of these
various circulating RNA populations.
For libraries made from synthetic RNA input or from
plasma RNA input, a fraction of reads (from 49% down
to 4%) did not map to the respective reference sequence set.
Prominent among these non-mapping sequences were ap-
parent plasmid vector sequences (data not shown), indicat-
ing that small amounts of laboratory nucleic acid contami-
nation from unrelated experiments can enter the workflow.
Read length distribution. The expected length distribution
of cDNA sequences obtained by the LQmethod should de-
pend upon the length of input material and on the size of
circular ligated material excised from the gel. In this analy-
sis, we sought to clone small RNAs in the range of 18–24 nt
from either synthetic miRNA mixtures or from total RNA
isolated from human blood plasma. We found the length
distribution of RNAs cloned from synthetic mixtures us-
ing the LQmethod was consistent regardless of input RNA
concentration, the addition to heat prior to the RT step, or
the absence of biotin. Interestingly, the cDNA length distri-
bution of the LQ method included a 17–20 nt fraction that
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was significantly reduced in the length distribution isolated
from the 2-linker method (Figure 4A), perhaps owing to the
additional size-specific gel purification step included in the
2-linker method.
To assess length distribution of RNAs cloned from total
plasma RNA, we divided reads into three groups: (i) hu-
man miRNAs (excluding the highly abundant miR-451a;
see below for explanation), (ii) other small RNAs mapping
to the human genome and (iii) reads that did not match the
human genome. For miRNAs, the majority of reads (72%)
range in length from 20 to 22 nt. Similar to what we ob-
served with the miRNA mixtures, shorter reads (22%) in-
clude small RNA fragments that map to miRNAs and re-
flect mainly truncation at the 3′ ends (data not shown), and
the remaining reads are sequences longer than 22 nt. More-
over, the size distribution for these sequences, as well as
other human and non-human small RNAs, falls within the
size range expected from the size selection step of circular-
ized cDNA in our protocol (Figures 2 and 4B; Materials
and Methods section).
5′ and 3′ end nucleotide bias. In order to asses potential
nucleotide-generated bias in either the ligation of RNA
to the 3′ adapter or in the circular ligation of generated
cDNAs, we examined the 5′ and 3′ nucleotides of se-
quences cloned from the sequence-diverse LT-miRNAmix-
ture. Overall, we observed a relative increase in 5′ Adenine
(A) and a decrease in 5′ Cytosine (C) in the LQmethod ver-
sus the 2-linker method (Figure 5A). This bias may be at-
tributed to the use of different enzymes in the 5′ end ligation
reactions. In the LQ method, CircLigase II is used to ligate
the 3′ end of the cDNA (corresponding to the 5′ nt of the
RNA) to the 5′ end of the RT primer, whereas the 2-linker
method utilizes T4 RNA ligase I to ligate the 5′ end of RNA
to a 5′ end adapter. T4 RNA ligase I exhibits sequence de-
pendent ligation preferences (33) that very likely differ from
those of CircLigase II. Interestingly, the CircLigase II en-
zyme exhibits a preference for ligation of 3′ Thymine (T) to
5′ Guanine (G) (Epicentre personal communication). Our
LQRToligo contains a 5′ G, and so this intrinsic T-to-G lig-
ation bias for CircLigase II could explain our observed en-
richment in LQ libraries for cDNA sequences correspond-
ing to RNAs containing a 5′ A (Figure 5A). Additionally,
the 2-linker method employs 5′ end adapters with different
nucleotides at the 3′ end (Table 1). Observed sequence bias
among the two libraries generated by the 2-linker method is
likely due to the sequence variation at the 3′ end (33,40,41).
In contrast, the 3′ end ligations in both methods utilize the
same enzyme, truncated and mutated T4 RNA ligase 2 (T4
Rnl2tr K227Q). Therefore, no 3′ nucleotide (3′ nt) bias was
expected in libraries generated from the two different meth-
ods, and indeed no significant difference was observed (Fig-
ure 5B).
Affect of biotin incorporation on sequence accuracy. To our
knowledge, this is the first use of biotinylated nucleotide
incorporation into cDNAs generated from linker-ligated
RNA. Moreover, at the outset, it was not clear how compe-
tent SuperScript III (Invitrogen) would be at incorporating
biotinylated nucleotides or whether the fidelity of Amplitaq
Gold DNA Polymerase (Invitrogen) would be impacted by
the presence of biotinylated nucleotides in the cDNA tem-
plate. Therefore, we sought to determine whether incorpo-
ration of biotinylated A and biotinylated C could lead to
preferential isolation of RNAs with a high Guanine (G)
and/orUracil (U) content, and/or whether biotinylated nu-
cleotides would be mutagenic in this context. We compared
theG/U content of mapped reads from the 2-linker method
to the mapped reads from the LQ method and found no
significant difference between the two populations (Figure
5C). As a more direct comparison, using the LQ method,
50 fmol of LT-miRmix was cloned with and without bi-
otin incorporation. Consistent with comparison of the LQ
and 2-linker methods, we found no significant difference in
the G/U content of sequences isolated in the presence or
absence of biotin (Figure 5C). Additionally, we examined
the relationship between read count (as measured by pro-
portion of reads) and G/U content and found that G/U
content did not directly correlate with read count when
either high (2.5 pmol) or low (500 amol) amounts of 29-
miRmix RNA was cloned (Supplementary Figure S4). To-
gether, these results indicate that incorporation of biotiny-
lated A and C does not appreciably affect the base com-
position of cDNAs recovered in the biotin-containing LQ
procedure. Note that the RT reaction contains a mixture of
biotinylated and non-biotinylated dCTP and dATP in ra-
tios of 0.54:1 and 0.43:1, respectively. These ratios were op-
timized for cloning of small RNA cDNAs; it is possible that
the proportion of biotinylated nucleotides in the RT reac-
tion would need to be adjusted for applications involving
the generation of appreciably longer cDNAs.
To assess possible mutagenic affects of biotinylated nu-
cleotides, the LT-miRmix subset reference (Materials and
Methods section) was used to compare any apparent muta-
tion rates at G and U positions among sequences generated
from each cloning method as well as from the LQ method
with and without biotin incorporation. We did not observe
any significant differences in nucleotide representation, in-
dicating that the incorporation of biotinylated nucleotides
was not appreciably mutagenic (Figure 5D).
5′ additions, 3′ variations and miRNA isoforms. Our LQ
method involves generation of cDNAs without a 5′ linker,
offering the advantage of cloning material independent of
the presence of a 5′ monophosphate structure. However, ab-
sence of a linker sequence at the 5′ end of the template RNA
introduces the potential for confounding effects of termi-
nal transferase (TdT) activity of the reverse transcriptase.
Although Superscript III reverse transcriptase has minimal
TdT activity, we nevertheless identified significant 5′ nt ad-
ditions during the early stages of method development (li-
brariesD1 andD2, Figure 6A).Wewere able to reduce these
5′ additions from >22% (in libraries D1 and D2) to <3%
(in libraries 1-4D) by reducing the quantity of RT enzyme
to 0.5 units in each reaction, and by shortening the reaction
time to 5 min (Figure 6A).
Because miRNA 3′ end heterogeneity has been charac-
terized in biological samples (42,43), we sought to verify
the ability of our LQ cloning method to identify these se-
quence variations. To do so, we generated a profile of se-
quences with length variability in the LT-miRmix subset
reference as described in the Materials and Methods sec-
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tion. Sequence length profiles identified in the LQ versus 2-
linker method indicate a similar ability for both methods to
clone a wide range of miRNAs including those with 3′ end
heterogeneity (Figure 6B). Due to the 5′ independent na-
ture of our protocol, it was not surprising that we isolated
miRNAs with 5′ end truncations from both the synthetic
miRNAmixtures analyzed (data not shown). It is likely that
these truncated molecules are due to heterogeneity arising
at oligo synthesis or are generated by spurious base hydrol-
ysis. Importantly, these sequence variations are missed by
cloningmethods employing a 5′ linker ligation that is depen-
dent upon a 5′ phosphate and their identification highlights
the importance of analyzing replicate libraries and employ-
ing differential analysis of the same method.
Interestingly, when plasma-derived miRNAs were com-
pared to miRBase sequence annotations we identified a
number of 5′ and 3′ differences between the annotated
sequences and those obtained in our libraries (data not
shown). Such apparent miRNA isoforms (isomiRs) could
reflect alternative processing of miRNA transcripts or in-
correct sequence annotation. IsomiRs are of interest, since
alterations in the 5′ end of a miRNAwould change the seed
sequence, and therefore alter target recognition, while 3′ end
modifications may affect miRNA stability and/or function
(44–46).
Sensitivity and reproducibility. To test method sensitivity,
we generated libraries across 3–4 orders of magnitudes us-
ing the synthetic miRNA mixtures (from 50 amol or 500
amol to 50 fmol) and across two orders of magnitude from
human blood plasma (10–110 plasma equivalents corre-
sponding to ∼90 amol–1,000 amol miRNA). From the LT-
miRNAmixture, using the LQ method we recovered>93%
of the reference miRNA sequences and >91% miRNA ref-
erence sequence coverage using the 2-linker method. In or-
der to rigorously examine the ability to clone miRNAs in a
sequence independent manner, libraries generated from de-
creasing input concentrations of the 29-miRmix were ana-
lyzed. Importantly, 100% of miRNA sequences in the mix-
ture were isolated (Table 3 and Figure 7). Compared to
methods developed by Zhang et al. (23) and Heyer et al.
(personal communication), we observed underrepresenta-
tion of some sequences using our method. This apparent
sequence bias became more pronounced with lower input
concentrations. However, we were unable to identify 5′ end,
3′ end or general sequence context features predictive of this
underrepresentation. It is possible that incorporation of ad-
ditional modifications to the LQ method may enhance uni-
formity of sequence recovery. Possible modifications could
include: heating RNA samples prior to 3′ adapter ligation,
the use of PEG-8000 in ligation reactions, a degenerate 5′
end of the RT oligo and further optimization of enzymatic
steps including buffer compositions (23,33,41,47–49). Ad-
ditionally, it is important to note that use of the LQmethod
enables generation of libraries from significantly less mate-
rial than these other methods as well as those commercially
available.
Cloning from human blood plasma demonstrates recov-
ery of a range of 127–223 mature miRNA sequences that
had ≥10 reads per million for those reads that mapped the
human genome. This range is dependent upon the depth
of the library examined and the extent of hemolysis that
could be indicated by miR-451a representation (see below
for explanation of miR-451a) (Table 3). Together, these data
demonstrate significant sequence coverage and identifica-
tion using our LQ cloning method.
To assess the consistency of sequences recovered by the
LQ approach, we examined the correlation of sequence read
counts among libraries from the same source RNA. Read
counts from synthetic miRNA-derived libraries correlated
well whether from the same amount or varying amounts
of input RNA (Figure 8, dark blue boxes). Comparison
of reads from two libraries generated from the LQ method
demonstrates good correlation (Figure 9A). Not unexpect-
edly, there were some non-correlating outliers for certain
low abundance sequences. Generally, libraries generated
from the LQ method were more highly correlated (Figure
8, dark blue boxes) than those generated using the 2-linker
method (Figure 8, red box, and Figure 9B). Finally, we
found that while libraries generated by the LQ method and
2-linker method had similar read coverage, read counts for
individual sequences were not well correlated between the
two methods (Table 3 and Figure 9C).
To assess reproducibility between sequencing platforms,
we generated a single library and then amplified the library
with either Ion Torrent (Libraries 2A–2D) or Illumina (Li-
braries 4A–4D) specific adapters at the second round of
PCR. Sequencing on the Ion Torrent or Illumina platform
yielded similar percentages of reference sequence covered
(Table 3) and high correlation of sequence read counts in
corresponding libraries (generated from the same input ma-
terial) (Figure 8, light blue boxes).
Analysis of miRNA read counts isolated from human
blood plasma showed correlation above 0.98 for all library
comparisons (data not shown). This substantiates the view
that our LQ method is sufficiently sensitive and repro-
ducible for application in the context of scarce clinical sam-
ples containing very low quantities of RNA.
miRNA repertoire of human blood plasma. Identification of
miRNAs in blood plasma (4) has led to the characterization
and profiling of circulatingmiRNApopulations in a variety
of disease contexts where the miRNA expression has been
shown to indicate tissue damage and disease status (for ex-
amples see 2,50–53). A confounding issue to the circulat-
ing miRNA profile is the presence of blood-cell-associated
miRNAs (54). In particular, themiRNA repertoire detected
in plasma RNA is highly sensitive to the degree of hemol-
ysis that can occur during sample isolation and process-
ing (54,55). Remarkably, even traces (0.031% (v/v)) of red
blood cells in plasma can alter the miRNA expression pro-
file compared to non-hemolyzed samples (56).
Examination of cDNA libraries prepared from hu-
man blood plasma identified a range (127–223) of signifi-
cantly expressedmature miRNAs. Analysis of miRNA read
counts done on all cDNA libraries revealed significant rep-
resentation of blood-cell-independent miRNAs as well as a
number of miRNAs that have not been carefully studied in
the context of hemolysis (Table 4). Consistent with previous
findings, we also identified hemolysis-associated miRNAs.
For example, we observed that miR-451a accounted for 58–
82% of all reads that map to the human genome (Figure 10),
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Figure 9. Scatter plots comparing miRNA reads from different library
preparations and sequencing methods. (A) Comparison of miRNA reads
generated by LQ cloning method originating from 50-fold difference in in-
put RNA concentration. (B) Comparison of miRNA reads generated by
2-linker cloning method originating from 10-fold dilution of input RNA
concentration. (C) Comparison of miRNA reads generated by LQmethod
versus 2-linker method. R = correlation coefficient between the two com-
pared libraries.
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Figure 10. Small RNAs identified in human blood plasma. Total small
RNA content in cDNA libraries generated from human blood plasma.
indicating that these blood plasma samples had suffered sig-
nificant hemolysis. Because miR-451a reads constituted a
predominant and variable fraction of our libraries, we ex-
cluded miR-451a reads for certain aspects of the analysis of
the other miRNAs represented in the libraries.
DISCUSSION
Deep sequencing of small RNA cDNA libraries from bi-
ological samples enables the discovery and quantitation
of RNA transcripts, including miRNAs and other small
noncoding RNAs, associated with distinct developmental,
physiological or pathological states. Ideally, it is desirable
to resolve transcriptional profiles on the level of individ-
ual cells, or in small samples of experimental material, such
as tissue biopsies or biofluids. Single-cell RNA-seq meth-
ods have been developed for cloningmRNA (18,20–22), but
not yet for small noncoding RNAs. cDNA library prepara-
tion has been reported using samples of small RNA isolated
from human blood plasma, where the yield of RNA was in
the nanogram range (14). However, the quantity of RNA
available from clinical samples, especially biofluids, is often
far less than a nanogram, even in the sub-picogram range.
Accordingly, we developed a robust, sensitive and techni-
cally straightforward protocol (LowQuantity, LQ,method)
through which very small quantities of input RNA can be
used to generate cDNA libraries for deep sequencing. The
LQmethod permits the preparation of cDNA libraries from
sub-picogram amounts of RNA− at least 1,000-fold less in-
put than for existing approaches (for examples see (57) and
(58)).
We developed and tested the LQ cloning protocol us-
ing two synthetic miRNA mixtures as input, followed by
analysis of sequence data obtained from the LQ libraries
along with that generated using a well-established 2-linker
cloning method (13). The coverage of sequences in the ref-
erence set was >93% for LQ libraries, somewhat greater
than that of libraries generated by the 2-linker method. The
length distributions of insert sequences were similar for the
two methods, although there was greater representation of
shorter (17–20 nt) inserts for the LQ method perhaps re-
flecting the multiple size-selection steps utilized by the 2-
linker method. Importantly, the 2-linker method requires
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Table 4. Top-40 miRNAs isolated from human blood plasma
miRNA
Average reads per
million Hemolysis associated
hsa-miR-451a 685,118 yes56,55,65,54
hsa-miR-144-3p 33,490 yes65
hsa-miR-16-5p 26,367 yes64,56,55,54
hsa-miR-15a-5p 10,525
hsa-miR-22-3p 6,994
hsa-miR-20a-5p 4,833 yes55
hsa-miR-142-3p 3,852 no55
hsa-let-7g-5p 3,387
hsa-miR-29c-3p 3,326
hsa-miR-486-5p 3,267 yes54
hsa-miR-223-3p 2,950 no64,56,55,65,54
hsa-miR-93-5p 2,561 no55
hsa-miR-15b-5p 2,330 yes64,56
hsa-miR-103a-3p 2,301 yes55
hsa-miR-21-5p 2,264 yes55
hsa-let-7i-5p 2,191
hsa-miR-26a-5p 1,979
hsa-miR-101-3p 1,915
hsa-miR-107 1,911
hsa-miR-92a-3p 1,682 yes56,54
hsa-miR-142-5p 1,568 no55
hsa-miR-126-3p 1,448 no55
hsa-miR-23a-3p 1,348 no63
hsa-miR-29a-3p 1,275 no55
hsa-miR-30e-5p 1,261
hsa-miR-27a-3p 1,215
hsa-miR-185-5p 1,156
hsa-let-7a-5p 1,089 no54
hsa-miR-29b-3p 1,001
hsa-miR-26b-5p 943
hsa-miR-25-3p 928
hsa-let-7b-5p 902 yes55
hsa-miR-19b-3p 870
hsa-miR-122-5p 852 no64,54,66, yes55
hsa-miR-425-5p 767 yes55
hsa-miR-32-5p 757
hsa-miR-18a-5p 722
hsa-let-7f-5p 701
hsa-miR-24-3p 658 no55, slightly64
hsa-miR-146a-5p 512 no55
The average (in reads per million) of indicated mature miRNAs in libraries
6A-8E. Hemolysis association, where clearly identified, is referred to and
reference(s) are indicated.
dramatically more input material than the LQ method, as
each of the size selection steps contributes to material loss.
Because the two methods utilized different enzymes in
5′ end ligation reactions, we examined any ligation-based
biases through analysis of both 5′ and 3′ end nt profiles.
The increase in 5′ A and decrease in 5′ C observed in the
LQ method can be attributed to the use of CircLigase II
in our method versus T4 RNA ligase I in 2-linker method.
Additionally, different ligation reaction temperatures (60◦C
for CircLigase II and ≤15◦C for T4 RNA ligase I) are also
known to affect ligation in a sequence dependent manner
and are likely to contribute to the observed 5′ nt differences
as well. As expected, we saw no difference with 3′ end nt
profiles, likely due to the fact that the same enzyme and re-
action conditions were used in both methods.
We demonstrate systematic isolation of biotin-containing
cDNAs using streptavidin beads. Because this is, to our
knowledge, the first use of biotinylated nucleotides in this
manner, we analyzed our data for evidence of sequence bias
or mutagenesis that might have been introduced by the use
of biotinylated nucleotides. We could discern no evident ef-
fect of biotin incorporation on either the base composition
of the sequences obtained, or on the frequency of apparent
nucleotide substitutions.
We did detect effects of cloning method on the frequency
of non-templated nucleotides at the 5′ end of the RNA se-
quences. We traced these events to likely residual termi-
nal transferase (TdT) activity of the Superscript III reverse
transcriptase. We were able to minimize TdT activity by
optimizing the RT reaction conditions such that the fre-
quency of untemplated additions is a manageable 2–3% of
sequences. The knowledge of expected 5′ addition rates can
be used to identify additions that are not due to enzyme ac-
tivity and a correction can be incorporated into future com-
putational pipelines. Those sequences with 5′ addition rates
significantly higher than that expected fromRT enzyme ter-
minal transferase activity could be assessed further to deter-
mine their biological significance. However, identification
of ≤3% 5′ terminal additions cannot be distinguished from
background terminal transferase activity. Sequence length
variation at the 3′ end of sequences was similar in both the
LQ method and 2-linker method.
Finally, to examine the sensitivity and reproducibility of
the LQ method, we compared libraries generated from a
broad range of quantities of input RNA. In doing so, we
identified a high correlation of the sequence content be-
tween libraries generated from RNA content ranging over
four orders of input material. Examination of the equimo-
lar 29-miRmix revealed that, for some miRNAs, such as
members of the let-7 family, read counts are reflective of
relative sequence abundance while for other sequences (e.g.
miR-205), read counts do not necessarily reflect relative
abundance. This phenomenon becamemore pronounced as
RNA input concentrations decreased (Figure 7). These ob-
servations reveal one limitation in the described method.
As such, read counts are not necessarily reflective of ab-
solute sequence abundance and cannot be used to com-
pare different small RNAs within the same library or across
libraries prepared from different input concentrations of
RNA. However, the method is appropriate for cloning cD-
NAs derived from very small amounts of starting material,
and for quantifying the levels of a specific sequence across
different samples, provided that libraries are prepared from
similar amounts of input RNA.
Although we identified similar reference sequence cover-
age for the LQ method compared to conventional 2-linker
cloning, the read count representation for individual se-
quences varied between the two methods. These differences
could reflect the differing conditions for ligation and RT re-
actions between the methods, or sequence-dependent sam-
ple loss. Moreover, the LQ method permits correction for
PCR hotspot reads whereas the 2-linker method did not in-
corporate such provisions in this implementation. Impor-
tantly, we devised a method that uses the randomer se-
quence incorporated into the RT oligo to identify PCR hot
spots and correct for them. Several works have explored the
use of random sequences to correct for PCR-induced ar-
tifacts (18,59–62). These methods rely on the assumptions
that (i) the number of randomer sequences is more than the
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number of distinct molecules and/or (ii) each randomer has
an equal probability of being observed. The first assump-
tion is needed in order to avoid saturation of a single se-
quence with the full randomer pool and to enable collaps-
ing the observed read count to the number of observed ran-
domer sequences. Ourmethod is designed to detect and cor-
rect hot spots in both saturated and unsaturated sequences.
Thus a 4 nt randomer was sufficient and use of a longer, 6
nt, randomer did not show any significant change in terms
of read collapsing. In regard to the second assumption, our
data show that randomer sequences are not equally dis-
tributed. Rather, in some cases there is a 1,000-fold differ-
ence between the least and most abundant randomers. As
a result, we assess the distribution of randomers in each
library separately, by identifying a set of sequences that
do not show a sharp bias to any particular randomer se-
quences. Therefore, we found that for small RNA libraries,
a 4 nt randomer is necessary and sufficient to detect and
correct for PCR hotspots.
When applying the LQ to human plasma RNA we were
able to reproducibly clone cDNA from RNA isolated from
10 –100 l of human blood plasma (estimated 90 amol –
1,000 amol miRNA). We found that miRNAs constitute
the major fraction of sequences cloned from human blood
plasma, and our sequences represented from 127 to 223 dis-
tinct miRNA species with read counts >10 reads per mil-
lion, similar to other analysis of human blood plasma per-
formed with more material (5,63). Consistent with previ-
ous findings that heamolysis can significantly affect circu-
lating miRNA profiles (54–56,63–65), miRNA-451a reads
were dramatically predominant in our libraries. As the bi-
ological relevance of miRNA-451a and other potentially
heamolysis-associated miRNAs in samples is determined,
sequences identified as background can be removed prior
to library generation using hybridization/bead capture or
hybridization/digestion techniques. Importantly, the circu-
latingmiRNAprofiles that we identified by deep sequencing
include numerous plasma-borne miRNAs that are known
to not originate in blood cells (Table 4) (54,55,63–66).
As expected, we identified other RNA sequences (besides
miRNAs) that would be anticipated from a method that
does not select for 5′-phosphate containing RNAs. These
non-miRNA sequences included rRNA fragments, tRNA
fragments, YRNA (37) and sequences annotated as piRNA
(67–70). Together, these data from libraries made from hu-
man blood plasma confirm the highly sensitive and repro-
ducible nature of the method as well as the ability to clone a
broader repertoire of small RNA sequences than any single
method previously published. Thus, this method has broad
applications in a clinical setting, making it feasible to gen-
erate cDNA libraries from human biofluids as well as from
small and scarce tissue specimens including biopsy tissue
blocks and small numbers of individual cells isolated from
laser capture microdissection of heterogeneous cell popula-
tions (71,72).
We have developed a novel, robust method to clone small
amounts ofRNA.While the limited amounts of inputmate-
rial we have cloned is unprecedented, our findings do reveal
possibilities for further improvement and minimization of
sequence biases (23,33,41,47–49). Importantly, features of
the LQ method, including utilization of barcode and ran-
domer sequences, provide the opportunity to pool samples
early in library generation thereby permitting exploration
of cloning from even more limiting sample concentrations.
Additionally, further development toward removal of pre-
cipitation as well as gel and column purification steps will
enable the LQ method to be applied to high-throughput,
robotic, applications.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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